Cost-Effectiveness Analysis of HPV Extended versus Partial Genotyping for Cervical Cancer Screening in Singapore
出版年份 2023 全文链接
标题
Cost-Effectiveness Analysis of HPV Extended versus Partial Genotyping for Cervical Cancer Screening in Singapore
作者
关键词
-
出版物
Cancers
Volume 15, Issue 6, Pages 1812
出版商
MDPI AG
发表日期
2023-03-17
DOI
10.3390/cancers15061812
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Clinical performance of the BD Onclarity extended genotyping assay for the management of women positive for human papillomavirus in cervical cancer screening
- (2022) Karena D Volesky et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- HPV prevention and control – The way forward
- (2022) Alex Vorsters et al. PREVENTIVE MEDICINE
- Effects of the Prophylactic HPV Vaccines on HPV Type Prevalence and Cervical Pathology
- (2022) Ian N. Hampson Viruses-Basel
- The Clinical Utility of Extended High-Risk HPV Genotyping in Women With ASC-US Cytology
- (2022) Wei Jiang et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Precancerous cervical lesions caused by non-vaccine-preventable HPV types after vaccination with the bivalent AS04-adjuvanted HPV vaccine: an analysis of the long-term follow-up study from the randomised Costa Rica HPV Vaccine Trial
- (2022) Jaimie Z Shing et al. LANCET ONCOLOGY
- Health care provider's experience and perspective of cervical cancer screening in Singapore: A qualitative study
- (2022) Brandon Wen Bing Chua et al. Frontiers in Public Health
- HPV Tests Comparison in the Detection and Follow-Up after Surgical Treatment of CIN2+ Lesions
- (2022) Fabio Bottari et al. Diagnostics
- Human Papillomavirus: Challenges and Opportunities for the Control of Cervical Cancer
- (2022) Patricia Piña-Sánchez ARCHIVES OF MEDICAL RESEARCH
- IPVS policy statement on HPV nucleic acid testing guidance for those utilising/considering HPV as primary precancer screening: Quality assurance and quality control issues
- (2022) Suzanne M. Garland et al. JOURNAL OF CLINICAL VIROLOGY
- Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative
- (2022) Deependra Singh et al. Lancet Global Health
- Which is the best management for women with normal cervical cytologic findings despite positivity for non-16/18 high risk human papillomaviruses?
- (2022) Ming Wu et al. Frontiers in Public Health
- Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesia
- (2021) Michael L. Ganz et al. JOURNAL OF MEDICAL ECONOMICS
- 2020 List of human papillomavirus assays Suitable for primary cervical cancer screening
- (2021) M. Arbyn et al. CLINICAL MICROBIOLOGY AND INFECTION
- Cost-effectiveness analysis of the nonavalent human papillomavirus vaccine for the prevention of cervical cancer in Singapore
- (2021) Lee Cheng Phua et al. VACCINE
- Clinical Validation of the Onclarity Assay After Assay Migration to the High-Throughput COR Instrument Using SurePath Screening Samples From the Danish Cervical Cancer Screening Program
- (2021) Ditte Møller Ejegod et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Predicting Hospital Resource Use During COVID-19 Surges: A Simple but Flexible Discretely Integrated Condition Event Simulation of Individual Patient-Hospital Trajectories
- (2021) J. Jaime Caro et al. VALUE IN HEALTH
- Risk stratification for cervical neoplasia using extended high‐risk HPV genotyping in women with ASC‐US cytology: A large retrospective study from China
- (2021) Xiang Tao et al. CANCER CYTOPATHOLOGY
- Worldwide use of HPV self-sampling for cervical cancer screening
- (2021) B. Serrano et al. PREVENTIVE MEDICINE
- Are We Facing a New Colposcopic Practice in the HPV Vaccination Era? Opportunities, Challenges, and New Perspectives
- (2021) Ankica Lukic et al. Vaccines
- Economic Evaluation of Sequences of Biological Treatments for Patients With Moderate-to-Severe Rheumatoid Arthritis and Inadequate Response or Intolerance to Methotrexate in France
- (2020) Salah Ghabri et al. VALUE IN HEALTH
- Impact of HPV vaccination on cervical screening performance: a population-based cohort study
- (2020) Jiayao Lei et al. BRITISH JOURNAL OF CANCER
- Association of HPV35 with cervical carcinogenesis among women of African ancestry: Evidence of viral‐host interaction with implications for disease intervention
- (2020) Maisa Pinheiro et al. INTERNATIONAL JOURNAL OF CANCER
- Benefit and burden in the Dutch cytology-based versus high-risk human papillomavirus-based cervical cancer screening program
- (2020) Diede L. LOOPIK et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Leveraging DICE (Discretely-Integrated Condition Event) Simulation to Simplify the Design and Implementation of Hybrid Models
- (2020) J. Jaime Caro et al. VALUE IN HEALTH
- Extended HPV Genotyping to Compare HPV Type Distribution in Self- and Provider-Collected Samples for Cervical Cancer Screening
- (2020) Eliane Rohner et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Using Discretely Integrated Condition Event Simulation To Construct Quantitative Benefit–Risk Models: The Example of Rotavirus Vaccination in France
- (2020) Hugo Arlegui et al. CLINICAL THERAPEUTICS
- The Triage Effectiveness of an Extended High-Risk Human Papillomavirus Genotyping Assay for Women with Cytology Showing Atypical Squamous Cells of Undetermined Significance in China
- (2020) Diling Pan et al. Risk Management and Healthcare Policy
- Incidence, persistence and clearance of cervical human papillomavirus among women in Guangdong, China 2007–2018: A retrospective cohort study
- (2020) Meijuan Li et al. Journal of Infection and Public Health
- Changes in Cervical Human Papillomavirus (HPV) Prevalence at a Youth Clinic in Stockholm, Sweden, a Decade After the Introduction of the HPV Vaccine
- (2019) Andreas Ährlund-Richter et al. Frontiers in Cellular and Infection Microbiology
- Clinical and analytical performance of the BD Onclarity HPV Assay with SurePath screening samples from the Danish cervical screening program using the VALGENT framework
- (2019) Jesper Hansen Bonde et al. JOURNAL OF CLINICAL MICROBIOLOGY
- The Onclarity Human Papillomavirus Trial: Design, methods, and baseline results
- (2018) Mark H. Stoler et al. GYNECOLOGIC ONCOLOGY
- Impact of HPV-vaccination on outcome of cervical cytology screening in Denmark - a register based cohort study
- (2018) Lise Holst Thamsborg et al. INTERNATIONAL JOURNAL OF CANCER
- Human Papillomavirus Genotype Distribution Among 18,815 Women in 13 Korean Cities and Relationship With Cervical Cytology Findings
- (2017) Eun-Hee Nah et al. Annals of Laboratory Medicine
- Infections with multiple high-risk HPV types are associated with high-grade and persistent low-grade intraepithelial lesions of the cervix
- (2016) Louise De Brot et al. CANCER CYTOPATHOLOGY
- Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study
- (2016) S. Rachel Skinner et al. INTERNATIONAL JOURNAL OF CANCER
- VALGENT: A protocol for clinical validation of human papillomavirus assays
- (2016) Marc Arbyn et al. JOURNAL OF CLINICAL VIROLOGY
- Discretely Integrated Condition Event (DICE) Simulation for Pharmacoeconomics
- (2016) J. Jaime Caro PHARMACOECONOMICS
- The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds
- (2014) Henry C Kitchener et al. HEALTH TECHNOLOGY ASSESSMENT
- Prevalence of cervical human papillomavirus infection in healthy women is related to sexual behaviours and educational level: a cross-sectional study
- (2014) Sun Kuie Tay et al. INTERNATIONAL JOURNAL OF STD & AIDS
- Meta-Analysis on Prevalence and Attribution of Human Papillomavirus Types 52 and 58 in Cervical Neoplasia Worldwide
- (2014) Paul K. S. Chan et al. PLoS One
- Health-related quality of life and perception of anxiety in women with abnormal cervical cytology referred for colposcopy: an observational study
- (2013) Annu Heinonen et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Five-Year Risk of Recurrence After Treatment of CIN 2, CIN 3, or AIS
- (2013) Hormuzd A. Katki et al. Journal of Lower Genital Tract Disease
- Follow-up Testing After Colposcopy
- (2013) Hormuzd A. Katki et al. Journal of Lower Genital Tract Disease
- Human Papillomavirus Type Distribution in Invasive Cervical Cancer and High-Grade Cervical Intraepithelial Neoplasia Across 5 Countries in Asia
- (2012) Swee Chong Quek et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Modeling Good Research Practices—Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1
- (2012) J. Jaime Caro et al. VALUE IN HEALTH
- Comparison of Measurements of Human Papillomavirus Persistence for Postcolposcopic Surveillance for Cervical Precancerous Lesions
- (2010) J. C. Gage et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Single and multiple human papillomavirus infections in cervical abnormalities in Portuguese women
- (2010) A. Pista et al. CLINICAL MICROBIOLOGY AND INFECTION
- Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline
- (2009) Mark Schiffman et al. Infectious Agents and Cancer
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now